Enzoflam-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100mg, Paracetamol 325mg, and Serratiopeptidase 15mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides effective relief from pain and inflammation by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, offering symptomatic relief from mild to moderate pain and fever through central inhibition of prostaglandin synthesis. Serratiopeptidase is a proteolytic enzyme that facilitates the breakdown of inflammatory mediators and promotes the resolution of inflammation by enhancing tissue permeability and reducing edema. The synergistic combination of these three agents makes Enzoflam-SP particularly useful in managing musculoskeletal disorders, postoperative pain, dental pain, and inflammatory conditions such as arthritis and soft tissue injuries. It is indicated for short-term use to alleviate pain and inflammation while improving functional mobility. The tablet should be administered as per physician guidance, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, or bleeding disorders. Caution is advised in patients with hepatic or renal impairment. Enzoflam-SP offers a comprehensive approach to pain management by targeting multiple pathways involved in inflammation and pain perception.